Lecture notes. Written from the material of MIT 8.591J 2014, licensed CC BY-NC-SA 4.0. These are notes, not a transcript: the material has been reorganised and rewritten. This adaptation carries the same licence, and the original is linked above.
11. Clonal Interference and Fitness Landscapes¶
What this covers¶
This chapter finishes the course's discussion of clonal interference — competition between several beneficial mutant lineages present in a population at the same time — and then turns to fitness landscapes shaped by interactions (epistasis) between mutations. It assumes the previous lecture's results for a single beneficial mutation: a mutation of selective advantage \(s\) establishes (survives early stochastic loss) with probability of order \(s\), and establishment and fixation happen on characteristic timescales of order \(1/s\) and \((1/s)\ln N\) respectively, giving a criterion for when competing lineages can be ignored. Building on that, the chapter asks two separate questions: how fast does a population's mean fitness actually increase with time, with and without clonal interference; and, unrelated to speed, what a single completely measured fitness landscape can tell us about how repeatable evolution is.
Inferring a distribution of beneficial effects from lineage-tracking data¶
The setting is an E. coli population evolving in a new environment, split at the start into two equal, differently labeled halves. After a few hundred generations these populations typically improve in fitness by something like a percent or a few percent — the scale that keeps recurring below. As beneficial mutations arise in one half or the other and spread, the log-ratio of the two sub-populations, \(\log(F_1/F_2)\), stays flat near zero until a mutation establishes, then bends upward.
The question the paper (referred to in the lecture as the paper on the "equivalence principle") asks is: what underlying distribution of beneficial-mutation effect sizes \(p(s)\), together with what rate \(\mu_b\) of acquiring such mutations, would produce this histogram of times and slopes? It compares three qualitatively different shapes for \(p(s)\) — a delta function (every beneficial mutation has exactly the same effect), a uniform distribution on \([0, s_{\max}]\), and an exponential distribution — each specified by only two numbers, a mutation rate and a mean effect \(\langle s\rangle\). The three are not the only conceivable shapes; they are chosen to be as different from each other as possible, to make the point sharply.
Working out the ordering. For each shape, some range of \((\mu_b, \langle s\rangle)\) fits the data. Why must the mutation rate and mean effect needed be so different across the three shapes?
- Delta. With only one possible effect size, no clonal interference is needed at all to explain the basic shape of the data: one lineage acquires the single available beneficial mutation, of effect \(s\approx 5\)–\(5.5\%\) (the value that matches the observed slope), and it simply spreads. Explaining why some trajectories later flatten out needs the other side to pick up a mutation too, but that is a mild, occasional need for competition, not the dominant feature of the fit — which is why the delta fit works with the lowest mutation rate of the three.
- Uniform. Trying to use the same mean effect (\(\approx5\)–\(5.5\%\)) for a uniform distribution on \([0, 2\langle s\rangle]\) fails: it predicts trajectories peaked at roughly twice that value. The reason is that the mutation you actually observe spreading is not a uniformly random draw from \(p(s)\) — it has to survive early stochastic loss (probability of establishment \(\propto s\), so bigger draws survive more often), and if more than one lineage appears, it has to win the competition against the others, which again favors the larger of the sampled values. Both effects push the observed slopes above the mean of the underlying distribution. A uniform distribution that reproduces the same observed peak needs a smaller mean than the delta fit — the region that works has \(\langle s\rangle\approx3\%\), with the top of the range near \(6\%\), about half the delta value — and it needs a somewhat higher mutation rate than delta, since a couple of surviving draws are now needed before their maximum lands in the right place. The amount of clonal interference required is still modest: just sampling two or three values from the uniform and keeping the one that survives stochastic extinction already peaks the outcome well above the naive mean.
- Exponential. An exponential distribution weights small effects even more heavily, so matching the same observed slope now means sampling several characteristic scales out on the tail — the fit needs a mean around \(1\%\) (ranging from about \(0.5\%\) to \(1.5\%\) across the parameters that work), meaning the beneficial mutations that actually matter are being drawn from around \(e^{-5}\) or so out on the tail relative to that mean. Getting enough of those rare, large draws to dominate the observed dynamics needs a much higher mutation rate — of order a factor of \(100\) higher than for the other two distributions, across the range of parameters that fit — with a corresponding factor of about \(3\) range in the compatible mean.
So there is a consistent trend: the more \(p(s)\) is weighted toward small effects, the smaller its characteristic mean must be and the larger the mutation rate must be, in order to reproduce the same coarse statistics. This is the equivalence principle: bulk lineage-frequency data of this kind cannot pin down the shape of \(p(s)\) on its own, because the observed dynamics only ever samples a size-biased, competition-filtered tail of \(p(s)\) — never \(p(s)\) itself. What the data constrains, for each assumed shape, is a trade-off curve between \(\mu_b\) and \(\langle s\rangle\), not a unique answer. One constraint does survive regardless of shape: a mutation has to arise within the first few tens of generations to have had time to spread by the time it is observed, which puts a shape-independent floor under \(\mu_b\).
The rate of evolution without clonal interference¶
Set the distribution question aside and ask something more basic: how fast does the population's mean fitness \(\bar w\) actually increase, \(\Delta \bar w/\Delta t\)? While selection coefficients are small it barely matters whether fitness effects of successive mutations add or multiply — for \(s_1, s_2 \ll 1\), \((1+s_1)(1+s_2)\approx 1+s_1+s_2\) — so treating fitness as additive is a reasonable first model. Under it, and while the population hasn't yet run out of beneficial mutations to draw on (roughly true for the first several thousand generations before the curve bends over), the rate of evolution is a meaningful, roughly constant quantity to compute.
Work in the regime \(\mu_b N \ll 1\): the mutation rate is low enough relative to the population size that fixation of one mutation (\(\sim (1/s)\ln N\)) is much faster than the typical wait between successive establishments, so — using the previous lecture's criterion — clonal interference does not matter. Then:
- New mutations enter the population at rate \(\mu_b N\) (each of \(N\) individuals mutates at rate \(\mu_b\)).
- A mutation of effect \(s\) establishes with probability of order \(s\) (exactly \(s\) in some models, \(2s\) in others — the constant is model-dependent, the scaling is not).
- With nothing to compete against, every mutation that establishes eventually fixes, adding its full effect \(s\) to the mean fitness — nothing is wasted.
Putting these together, the rate of evolution is $$ v \equiv \frac{\Delta \bar w}{\Delta t} = \mu_b N \int p(s)\, s\cdot s\, ds = \mu_b N \langle s^2\rangle. $$
This is linear in \(\mu_b\): doubling the mutation rate doubles the rate at which mutations enter and, since nothing competes, doubles the rate of fixation. It is also linear in \(N\): doubling the population doubles the rate at which new mutations appear, and, provided \(s\) is not so small that near-neutral mutations start behaving specially (not the relevant regime for populations of order \(10^4\) or more), the establishment probability doesn't depend on \(N\), so the fixation rate doubles as well.
Why \(\langle s^2\rangle\) and not \(\langle s\rangle^2\): a mutation of size \(s\) enters \(v\) through two independent factors of \(s\) — once via its probability of establishing (\(\propto s\)) and once via the size of the increment it delivers if it does (\(=s\)). Two powers of \(s\) per successful mutation give \(\langle s^2\rangle\). For a delta distribution the distinction is invisible, since \(\langle s^2\rangle=\langle s\rangle^2\) trivially when \(s\) only ever takes one value; making the distinction vivid for a distribution with real spread needs a sharper example than a rough two-point sketch, and that was left as an open thread in the lecture rather than finished.
Where this breaks down: clonal interference and the Desai–Fisher–Murray model¶
Plotting \(\log v\) against \(\log N\) makes the crossover visible: for small \(N\) it is a straight line of slope \(1\) (the \(v\propto N\) result above). It cannot continue forever — once clonal interference sets in, the curve bends below that line and grows more slowly.
The mechanism: when two or more beneficial mutations are present at the same time, only one can ultimately fix. The population effectively keeps the maximum of the competing gains rather than their sum. Without competition you eventually get one mutation, then another, each adding its own \(s\); with competition you only keep the best of however many arose together, and the gap between "sum" and "maximum" widens as the population grows and more lineages compete simultaneously. The rate does not fall in absolute terms — it simply grows more slowly than it otherwise would, because some beneficial mutations are wasted.
Solving for the rate of evolution with clonal interference, for a general distribution of effect sizes, is a genuinely hard problem — hard experimentally and theoretically — and has been an active research question for roughly the last decade. One tractable simplification, due to Desai, Fisher and Murray (Current Biology, 2007), drops the distribution of effects altogether and assumes every beneficial mutation has exactly the same effect \(s\). The population's fitness distribution then becomes a set of discrete classes at fitness \(0, s, 2s, 3s, 4s,\dots\) relative to the least-fit class present.
Most of the population sits in some roughly steady-shaped bulk across these classes; a mutation picked up deep in the bulk doesn't change much, since everything there is already growing exponentially relative to the mean. What matters is the leading edge, or "nose": individuals that already carry several more mutations than the bulk. When one of those acquires yet another mutation, it extends the front of the distribution further ahead, and it is this leading-edge process that sets how fast the whole distribution — and hence the mean fitness — moves forward.
The model is still hard to solve exactly and the lecture does not reproduce the full derivation, but for large \(N\) the dominant behavior of the velocity is $$ v \sim s^2 \ln N, $$ in place of the linear-in-\(N\) result found without clonal interference. The \(s^2\) is the same combination as before (the delta-function case of \(\langle s^2\rangle\)); what clonal interference changes is the \(N\)-dependence, from linear to logarithmic — a much smaller payoff from a larger population once competing lineages are common. Real populations don't have every beneficial mutation carrying exactly the same effect, so this is a first-order model, but the qualitative crossover from linear to logarithmic growth is the point worth keeping.
Rugged fitness landscapes: the beta-lactamase example¶
A fitness landscape is rugged — has more than one peak, or blocks some uphill paths — when there is epistasis: the fitness effect of one mutation depends on which others are already present. Weinreich (2006) turned this from a purely theoretical picture into something measured directly, in a case where the interactions were known to matter: resistance conferred by the enzyme beta-lactamase (TEM-1) to a beta-lactam antibiotic. All natural variants of the enzyme can break down an older drug such as ampicillin, but they vary hugely in their ability to break down a newer one, cefotaxime — a version with none of five specific point mutations is essentially unable to break it down at all, while the version carrying all five breaks it down at very high rates. Of the five mutations, one is in the promoter and roughly doubles or triples expression; the other four are protein-coding, each changing a single amino acid.
Resistance was quantified by the Minimum Inhibitory Concentration (MIC): the lowest antibiotic concentration that stops growth of the population over a fixed window (20 hours), starting from a standard cell density. In practice this is read off a dilution series (concentration stepped down by a fixed factor from well to well) — the population grows up to some concentration and not above it, and that boundary is the MIC. (The mapping from MIC to absolute fitness is itself nontrivial, but for this landscape MIC is simply used as a monotonic stand-in for fitness.)
With five point mutations there are \(2^5 = 32\) possible genotypes. Weinreich constructed all 32, in the same genetic background, and measured the MIC of each — that is the entire experimental dataset in the paper. Everything else is analysis of the resulting, completely measured fitness landscape, which is itself unusual: a fitness landscape is normally something reasoned about abstractly, not something fully mapped from real measurements.
The measured landscape had exactly one peak — the genotype carrying all five mutations. This matters: if a population can only fix mutations that increase fitness at each step (evolution moves only "uphill"), then starting from the ancestral genotype and always taking some uphill step, it is guaranteed to reach that one peak eventually, no matter which uphill path it happens to take. A single peak means there is no way to get trapped at a suboptimal local maximum.
The landscape is nonetheless rugged in a different, more precise sense. There are \(5! = 120\) possible orderings in which the five mutations could be acquired one at a time, but only \(18\) of them have fitness increasing at every step; the other \(102\) are selectively inaccessible, because somewhere along that ordering the next mutation on the path would have to be one that does not increase MIC. A mutation that is neutral (or worse) is treated as unable to fix within a reasonable time in a population of, say, \(10^6\), when genuinely beneficial mutations are simultaneously available elsewhere to out-compete it — the same competitive logic as clonal interference, applied here to which paths are reachable rather than to speed. Even among the 18 monotonic orderings, not all are equally likely to be realized in an actual population, since the paths branch with unequal probability, so in practice only a handful of the 18 dominate.
The lecture's point in putting these two facts side by side: it is easy to read this landscape as extremely rugged, since \(102\) of \(120\) naive orderings are blocked — but that overstates it. It is a moderately rugged landscape, because there is still only one peak: ruggedness here constrains which path evolution takes without being able to trap it anywhere. A later laboratory-evolution study on a different antibiotic-resistance gene, from the same experimentalist, tested whether a landscape measured this way can actually predict what happens when a population is evolved in the lab, and found that — at least in some cases — it can: a hint that the course of evolution may be more predictable than it would otherwise seem.
Sources¶
- Transcript:
docs/computational-biology/mit-ocw/8591j-2014/recordings/recordings/efxjkhdbi6a.md(MIT 8.591J, Systems Biology, Fall 2014). Timestamps [02:08]–[38:00] for the equivalence-principle discussion; [38:00]–[1:05:00] for the rate of evolution and the Desai–Fisher–Murray model; [1:05:00]–end for the Weinreich beta-lactamase landscape. Administrative remarks about an upcoming exam ([01:02]–[02:08]) are omitted as boilerplate. - Referred to but not contained in this source: the lineage-tracking paper on the "equivalence principle" — named in the transcript as "Roy Kashoney's paper," almost certainly a mis-transcription of Roy Kishony; neither its title nor the figures it repeatedly points to (called "figure 3A" and "figure 4" in the lecture) are given, only described in speech.
- Desai, Fisher and Murray, Current Biology, 2007 — named and dated in the transcript, but its title and the full velocity expression are not given; only the model setup and the leading-order scaling \(v\sim s^2\ln N\) are stated.
- Weinreich, 2006 — named and dated in the transcript (on beta-lactamase/cefotaxime resistance); described in enough quantitative detail (MIC assay, five mutations, 32 genotypes, 120 orderings, the 102/18 split) to reconstruct directly, though its title is not given.
- The previous lecture's derivation of the establishment probability (\(\approx s\)) and the fixation timescale (\(\sim (1/s)\ln N\)) is referred to ("you should be able to derive this") but is not part of this transcript.
- Whatever was actually drawn on the board — the real trajectory plots, the MIC dilution series, the abundance-vs-fitness sketch — exists in this source only as spoken description; the figures themselves are not part of the transcript.
← 10. Single Molecules and Protein Bursts · Contents · 12. Three Views of Stochastic Kinetics →